VSTM
NASDAQ · Biotechnology
Verastem Inc
$4.34
+0.13 (+3.09%)
Open$4.20
Previous Close$4.21
Day High$4.37
Day Low$4.15
52W High$11.25
52W Low$3.55
Volume—
Avg Volume2.45M
Market Cap362.04M
P/E Ratio—
EPS$-2.51
SectorBiotechnology
Analyst Ratings
Strong Buy
15 analysts
Price Target
+223.7% upside
Current
$4.34
$4.34
Target
$14.05
$14.05
$11.84
$14.05 avg
$17.49
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 38.72M | 14.27M | 326.86M |
| Net Income | -262,396,086 | -167,775,411 | 9.66M |
| Profit Margin | -677.6% | -1,241.1% | 3.0% |
| EBITDA | -215,400,420 | -176,249,033 | 19.14M |
| Free Cash Flow | — | — | 10.52M |
| Rev Growth | +128.2% | +69.6% | +8.0% |
| Debt/Equity | 1.51 | 0.51 | 0.80 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.93 | +0.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $352.99 | +1.72% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.88 | +0.66% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $478.81 | +2.22% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $626.31 | +1.34% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $300.33 | +4.22% | 64.3 | 37.13B |